Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment*

収録刊行物

  • Critical Care Medicine

    Critical Care Medicine 33 (10), 2266-2277, 2005-10

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (6)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ